LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway ; volume:7 ; number:1 ; day:4 ; month:3 ; year:2024 ; pages:1-11 ; date:12.2024
Communications biology ; 7, Heft 1 (4.3.2024), 1-11, 12.2024

Creator: Zhang, Rongrong
Zhan, Yating
Lang, Zhichao
Li, Yifei
Zhang, Weizhi
Zheng, Jianjian

Contributor: SpringerLink (Online service)

DOI: 10.1038/s42003-024-05971-7

URN: urn:nbn:de:101:1-2405081008390.190388125097

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Rongrong
Zhan, Yating
Lang, Zhichao
Li, Yifei
Zhang, Weizhi
Zheng, Jianjian
SpringerLink (Online service)

Other Objects (12)

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Epigenetic regulation during hepatic stellate cell activation

Human hepatic stellate cell isolation and characterization

Anaphylatoxin C5a modulates hepatic stellate cell migration

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Related objects

Reset password